Attached files
| file | filename |
|---|---|
| EX-10.1 - EXHIBIT 10.1 - INTERPACE BIOSCIENCES, INC. | exhibit101.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported: February 22, 2012)
PDI, INC.
(Exact name of Registrant as specified in its charter)
DELAWARE | 0-24249 | 22-2919486 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
Morris Corporate Center 1, Building A
300 Interpace Parkway,
Parsippany, NJ 07054
(Address of principal executive offices and zip Code)
(862) 207-7800
Registrant's telephone number, including area code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
On February 22, 2012, PDI, Inc. (the “Company”) and Pfizer, Inc. entered into an amendment (the “Amendment”) to
the Amended and Restated Master Services Agreement, dated September 23, 2009 (as so amended, the “Master Services
Agreement”), pursuant to which, among other things, the term of the Master Services Agreement was extended until September
23, 2014.
The foregoing description of the Amendment is qualified entirely by reference to the Amendment, a copy of which is attached as Exhibit 10.1 hereto and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(c) | Exhibits | |||
Exhibit No. | Description | |||
10.1 | Amendment to Amended and Restated Master Services Agreement, dated February 22, 2012, by and among PDI, Inc. and Pfizer, Inc. | |||
* * * * * * *
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PDI, INC. | |
By: /s/ Jeffrey Smith | |
Jeffrey Smith | |
Chief Financial Officer | |
Date: March 6, 2012
Exhibit Index
Exhibit No. | Description | |||
10.1 | Amendment to Amended and Restated Master Services Agreement, dated February 22, 2012, by and among PDI, Inc. and Pfizer, Inc. | |||